Literature DB >> 1314194

Genetic alterations by human papillomaviruses in oncogenesis.

P A Lazo1, M I Gallego, S Ballester, E Feduchi.   

Abstract

The integration sites in the cellular genome of human papillomavirus are located in chromosomal regions always associated with oncogenes or other known tumor phenotypes. Two regions, 8q24 and 12q13, are common to several cases of cervical carcinoma and can have integrated more than one type of papillomavirus DNA. These two chromosomal regions contain several genes implicated in oncogenesis. These observations strongly imply that viral integration sites of DNA tumor viruses can be used as the access point to chromosomal regions where genes implicated in the tumor phenotype are located, a situation similar to that of non-transforming retroviruses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1314194     DOI: 10.1016/0014-5793(92)80175-g

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

Review 1.  JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process?

Authors:  Tatiana R Coelho; Luis Almeida; Pedro A Lazo
Journal:  Virol J       Date:  2010-02-18       Impact factor: 4.099

2.  Laser scanning confocal microscopy and quantitative microscopy with a charge coupled device camera improve detection of human papillomavirus DNA revealed by fluorescence in situ hybridization.

Authors:  G Lizard; M C Chignol; C Souchier; D Schmitt; Y Chardonnet
Journal:  Histochemistry       Date:  1994-04

Review 3.  Cellular proteins involved in papillomavirus-induced transformation.

Authors:  D C Swan; S D Vernon; J P Icenogle
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 4.  The molecular genetics of cervical carcinoma.

Authors:  P A Lazo
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

5.  Pulmonary tumors associated with the JC virus T-antigen in a transgenic mouse model.

Authors:  Akira Noguchi; Keiji Kikuchi; Takashi Ohtsu; Mitsuyo Yoshiwara; Yoshiyasu Nakamura; Yohei Miyagi; Huachuan Zheng; Yasuo Takano
Journal:  Oncol Rep       Date:  2013-10-02       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.